Becton, Dickinson and CompanyDownload PDFPatent Trials and Appeals BoardJan 11, 20212020005479 (P.T.A.B. Jan. 11, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/098,695 12/06/2013 Tracy L. Gustafson BECTON 3.0-082 DIV (0711) 1092 147462 7590 01/11/2021 Botos Churchill IP Law LLP 430 Mountain Avenue Suite 401 New Providence, NJ 07974 EXAMINER LAM, ELIZA ANNE ART UNIT PAPER NUMBER 3686 NOTIFICATION DATE DELIVERY MODE 01/11/2021 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): ip.docket@bd.com pto@bciplaw.com rbotos@bciplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte TRACY L. GUSTAFSON Appeal 2020-005479 Application 14/098,695 Technology Center 3600 Before ALLEN R. MacDONALD, JASON V. MORGAN, and MICHAEL J. ENGLE, Administrative Patent Judges. ENGLE, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Appellant1 appeals under 35 U.S.C. § 134(a) from the Examiner’s rejection of claims 13–31, which are all of the claims pending in the application. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 We use the word “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42(a). Appellant identifies Becton, Dickinson and Company as the real party in interest. Appeal Br. 2. Appeal 2020-005479 Application 14/098,695 2 TECHNOLOGY The application relates to a “rapid syndrome analysis apparatus and method.” Spec. Title. ILLUSTRATIVE CLAIM Claim 13 is illustrative and reproduced below: 13. A method for providing rapid syndrome analysis comprising: receiving, using a set of instructions stored on a computer readable medium of a computer, syndromatic surveillance count data for a plurality of past time blocks within a plurality of moving baseline intervals from a plurality of computer devices over a network; calculating, using the set of instructions, for each moving baseline interval, a trimmed moving weighted means and sigma of the received syndromatic surveillance count data of the past time blocks within that moving baseline interval; receiving, using the set of instructions, syndromatic surveillance count data for a current time block from a plurality of computer devices over the network; calculating, using the set of instructions, a plurality of cumulative sums (CUSUMs) using (a) the received syndromatic surveillance count data for the plurality of past time blocks, (b) the calculated trimmed moving weighted means and sigmas, and (c) the received syndromatic surveillance count data for the current time block, wherein each of the CUSUMs are calculated using at least one of a different moving baseline interval or a different predetermined threshold value within a first set of threshold values stored on the computer readable medium; comparing, using the set of instructions, the calculated CUSUMs with a plurality of predetermined threshold values within a second set of threshold values stored on the computer readable medium; and when the comparison indicates that a magnitude of one or more of the calculated CUSUMs exceeds a magnitude of one or Appeal 2020-005479 Application 14/098,695 3 more of the predetermined threshold values within the second set of threshold values: generating, using the set of instructions, one or more flag signals; and sending, using the set of instructions, an indication of a seriousness or an unusualness of a disease outbreak to a computer device over the network based on the one or more generated flag signals. REJECTION Claims 13–31 stand rejected under 35 U.S.C. § 101 as directed to a judicial exception without significantly more. Final Act. 2. ANALYSIS The Supreme Court has set forth a two part test for § 101 to determine whether the subject matter of a claim is patentable: (1) “whether the claims at issue are directed to” “laws of nature, natural phenomena, and abstract ideas” and (2) “whether the additional elements ‘transform the nature of the claim’ into a patent-eligible application.” Alice Corp. v. CLS Bank Int’l, 573 U.S. 208, 217 (2014) (quoting Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 79, 78 (2012)). “Eligibility under 35 U.S.C. § 101 is a question of law, based on underlying facts.” SAP Am., Inc. v. InvestPic, LLC, 898 F.3d 1161, 1166 (Fed. Cir. 2018). In 2019, the U.S. Patent & Trademark Office (“USPTO”) expanded on the Supreme Court’s test with revised guidance. USPTO, 2019 Revised Patent Subject Matter Eligibility Guidance, 84 Fed. Reg. 50 (Jan. 7, 2019) (“Guidance”); USPTO, October 2019 Update: Subject Matter Eligibility, available at https://www.uspto.gov/sites/default/files/documents/ Appeal 2020-005479 Application 14/098,695 4 peg_oct_2019_update.pdf (“Oct. Update”). Under that Guidance, we use the following steps to determine whether a claim recites the following items: USPTO Step Does the claim recite ___? MPEP § 1 A process, machine, manufacture, or composition of matter 2106.03 2A, Prong 1 A judicial exception, such as a law of nature or any of the following groupings of abstract ideas: 1) Mathematical concepts, such as mathematical formulas; 2) Certain methods of organizing human activity, such as a fundamental economic practice; or 3) Mental processes, such as an observation or evaluation performed in the human mind. 2106.04 2A, Prong 2 Any additional limitations that integrate the judicial exception into a practical application 2106.05(a)– (c), (e)–(h) 2B Any additional limitations beyond the judicial exception that, alone or in combination, were not “well-understood, routine, conventional” 2106.05(d) See Guidance, 84 Fed. Reg. at 52, 55, 56. In this case, there is no dispute under USPTO Step 1, so we begin our analysis under Prong 1 of USPTO Step 2A. Claim 13 recites, in part, the following limitations: calculating, . . . for each moving baseline interval, a trimmed moving weighted means and sigma of the received syndromatic surveillance count data of the past time blocks within that moving baseline interval; . . . calculating . . . a plurality of cumulative sums (CUSUMs) using (a) the received syndromatic surveillance count data for the plurality of past time blocks, (b) the calculated trimmed moving weighted means and sigmas, and (c) the received syndromatic surveillance count data for the current time block, wherein each Appeal 2020-005479 Application 14/098,695 5 of the CUSUMs are calculated using at least one of a different moving baseline interval or a different predetermined threshold value within a first set of threshold values stored on the computer readable medium; comparing . . . the calculated CUSUMs with a plurality of predetermined threshold values within a second set of threshold values stored on the computer readable medium; and when the comparison indicates that a magnitude of one or more of the calculated CUSUMs exceeds a magnitude of one or more of the predetermined threshold values within the second set of threshold values: generating . . . one or more flag signals . . . . Each of these “calculating”; “comparing”; and “generating” steps can be performed mentally or with pen and paper. As both Appellant and the Examiner note, the claims and the rest of the Specification do not put any minimum on the data size, see Reply Br. 4–5, so the claims permit a small enough sample size that the calculations can reasonably be completed in the human mind. See Ans. 4. Appellant has not identified any reason why these steps could not be performed in the human mind. Thus, claim 13 recites mental processes, which are abstract ideas. For Prong 2 of USPTO Step 2A, the additional limitations are (1) the two “receiving” steps; (2) the “sending” step; and (3) performing all the steps “using a set of instructions stored on a computer readable medium of a computer.” However, “receiving . . . syndromatic surveillance count data” for past or current time blocks “from a plurality of computer devices over a network” is merely insignificant pre-solution activity of data gathering. Ans. 4. Similarly, “sending . . . an indication of a seriousness or an unusualness of a disease outbreak to a computer device over the network based on the one or more generated flag signals” is merely insignificant Appeal 2020-005479 Application 14/098,695 6 post-solution activity equivalent to displaying the result. Id. The Federal Circuit has held that “the ‘realm of abstract ideas’ includes ‘collecting information, including when limited to particular content’”; “analyzing information by steps people go through in their minds, or by mathematical algorithms, without more, [which are] essentially mental processes”; “merely presenting the results of abstract processes of collecting and analyzing information, without more (such as identifying a particular tool for presentation) . . . as an ancillary part of such collection and analysis”; and “a combination of these abstract-idea categories.” FairWarning IP, LLC v. Iatric Sys., Inc., 839 F.3d 1089, 1093–94 (Fed. Cir. 2016) (quoting Elec. Power Grp., LLC v. Alstom S.A., 830 F.3d 1350, 1353 (Fed. Cir. 2016)). Performing the steps using instructions on a computer readable medium likewise fails to render the claims eligible because “[a]n abstract idea on ‘an Internet computer network’ or on a generic computer is still an abstract idea.” BASCOM Glob. Internet Servs., Inc. v. AT&T Mobility LLC, 827 F.3d 1341, 1348 (Fed. Cir. 2016). Appellant argues that “the present claims enable a computer to provide rapid syndrome analysis that ‘can be much more accurate and sensitive than prior art methods.’” Reply Br. 4 (quoting Spec. ¶ 57). However, “a claim for a new abstract idea is still an abstract idea.” Synopsys, Inc. v. Mentor Graphics Corp., 839 F.3d 1138, 1151 (Fed. Cir. 2016). “Groundbreaking, innovative, or even brilliant discovery does not by itself satisfy the § 101 inquiry.” Ass’n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576, 591 (2013). And here, we agree with the Examiner that “[w]hile Appellant[’]s algorithm may be more accurate than the prior art, it is an improvement to the abstract idea and not an Appeal 2020-005479 Application 14/098,695 7 improvement to a functioning of a computer or other technology.” Ans. 4–5. “It has been clear since Alice that a claimed invention’s use of the ineligible concept to which it is directed cannot supply the inventive concept that renders the invention ‘significantly more’ than that ineligible concept.” BSG Tech LLC v. BuySeasons, Inc., 899 F.3d 1281, 1290 (Fed. Cir. 2018). Appellant attempts to analogize the present claims to the USPTO’s Example 42. Appeal Br. 11–14. However, Example 42 explains that its claim 1—a method for transmission of notifications when medical records are updated—integrates the method into a practical application as follows: “Specifically, the additional elements recite a specific improvement over prior art systems by allowing remote users to share information in real time in a standardized format regardless of the format in which the information was input by the user.” Subject Matter Eligibility Examples: Abstract Ideas, 18–19 (Jan. 7, 2019), available at https://www.uspto.gov/sites/default/files/ documents/101_examples_37to42_20190107.pdf. Technical problems and solutions comparable to those of Example 42 (e.g., “remote users” sharing information in non-standardized formats in real time and the conversion of those disparate formats into one “standardized format”) are wholly lacking in the present claims. Here, both the problem (inability to quickly recognize an outbreak) and the solution (calculations using multiple CUSUMs and comparing to a threshold) exist even in the absence of computers or other technology. Appellant’s reliance on the technical problem and solution in McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1314 (Fed. Cir. 2016), is inapposite for similar reasons. Reply Br. 5–7. Thus, claim 13 fails to integrate the abstract idea into a practical application under Prong 2 of USPTO Step 2A. Appeal 2020-005479 Application 14/098,695 8 For USPTO Step 2B, we also agree with the Examiner that the additional limitations, whether alone or in combination, recite only well- understood, routine, and conventional components. Ans. 4. The Specification itself states that “[c]omputer 12 may be any computer now known or hereafter developed” and “includes software 20, as known, on computer readable medium 22 . . . such as a disc, cd, dvd or the like.” Spec. ¶ 25. The courts likewise have held that “receiving transmitted data over a network and displaying it to a user merely implicates purely conventional activities that are the ‘most basic functions of a computer.’” Intellectual Ventures I LLC v. Erie Indem. Co., 850 F.3d 1315, 1331 (Fed. Cir. 2017) (quoting Alice, 573 U.S. at 225). Appellant further argues that each of the dependent claims recite additional technological improvements. Appeal Br. 16–17. However, we agree with the Examiner that none of the additional limitations are “technological.” Ans. 5. Instead, they merely add minor details to either the calculations that can still be done mentally (e.g., setting the intervals to a certain number of days or excluding certain past values) or the insignificant extra-solution activities that are not technical (e.g., making the response a “color”). Id. Accordingly, we sustain the Examiner’s rejection of claims 13–31. Appeal 2020-005479 Application 14/098,695 9 OUTCOME The following table summarizes the outcome of the rejection: Claims Rejected 35 U.S.C. § Basis Affirmed Reversed 13–31 101 Eligibility 13–31 TIME TO RESPOND No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.36(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation